In a regulatory filing first seen by Citybizlist, Valeritas has 20 investors in the round so far.
Valeritas, a US-based maker of the V-Go drug patch for diabetes, has raised $9.4m of a planned $10m round.
In a regulatory filing first seen by Citybizlist, Valeritas has 20 investors in the round so far.
Valeritas’ primary investors include US-based corporate venturing unit Kaiser Permanente Ventures, Agate Medical Investments, a $60m fund with the backing of Clal Insurance, and venture capital firms MPM Capital, Pitango Venture Capital, Abingworth, US Venture Partners, Onset Ventures, ATV Capital, HLM Venture…
